Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
CeleCor Therapeutics, Inc. See All Filings	D/A	2024-08-21 10:01:06 UTC
Amount To Be Raised $45,500,000 Associated Brokers / Dealers N/A CIK Number 0001705381 Filed Document 0001705381-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-08-21 10:01:06 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
CeleCor Therapeutics, Inc. See All Filings	D/A	2023-08-03 12:07:04 UTC
Amount To Be Raised $42,500,000 Associated Brokers / Dealers N/A CIK Number 0001705381 Filed Document 0001705381-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-08-03 12:07:04 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
CeleCor Therapeutics, Inc. See All Filings	D	2022-03-08 14:56:34 UTC
Amount To Be Raised $7,500,000 Associated Brokers / Dealers N/A CIK Number 0001705381 Filed Document 0001705381-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-03-08 14:56:34 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
CeleCor Therapeutics, Inc. See All Filings	D	2021-05-10 10:38:09 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001705381 Filed Document 0001705381-21-000002 Exclusions or Exemptions 506b Accepted Date 2021-05-10 10:38:09 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
CeleCor Therapeutics, Inc. See All Filings	D	2017-05-03 15:18:41 UTC
Amount To Be Raised $25,000,000 Associated Brokers / Dealers N/A CIK Number 0001705381 Filed Document 0001705381-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-05-03 15:18:41 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity